Search - tctmd.com

Displaying 221 - 240 of 272

Sort: Relevancy | Date

News Daily News

Una Gran Minoría de Pacientes con Fibrilación Auricular de Bajo Riesgo Siguen Recibiendo Anticoagulantes

Salynn Boyles

April 28, 2015

News Opinion Editor's Corner

Editor’s Corner: The Watchman Story

Caitlin E. Cox

April 06, 2015

News Daily News

El Uso Crónico de un Antagonista de la Vitamina K Aumenta las Hemorragias Intrahospitalarias en Pacientes sometidos a PCI Primarias

Caitlin E. Cox

November 02, 2014

News Features

Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation

Todd Neale

October 10, 2014

News Conference News TCT 2014

Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation

Todd Neale

October 10, 2014

News Industry News

Efficacy and Safety Profile of Pradaxa® (dabigatran etexilate) Repeatedly Confirmed

July 23, 2014

News Industry News

New study to investigate dabigatran etexilate for prevention of recurrent stroke in high-risk patients

May 07, 2014

News Daily News

ROCKET AF Substudy: Rivaroxaban Safe, Effective in East Asian Patients

L.A. McKeown

April 29, 2014

News Daily News

ROCKET AF Analysis Isolates Predictors of Intracranial Hemorrhage in A-fib Population

L.A. McKeown

April 22, 2014

News Daily News

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Yael L. Maxwell

January 01, 2014

News Daily News

Meta-analyses: Novel Anticoagulants Halve Intracranial Hemorrhage vs. Warfarin

January 01, 2014

News Daily News

Meta Análisis: Comparados con la Warfarina los Nuevos Anticoagulantes Reducen a la Mitad las Hemorragias Intracraneales

January 01, 2014

News Daily News

Rivaroxaban Antidote Appears Safe, Effective in Early Study

December 30, 2013

News Daily News

Oral Direct Thrombin Inhibitors Linked to Increased MI Risk

L.A. McKeown

October 04, 2013

News Daily News

Los Inhibidores Orales Directos de la Trombina se asocian a un Mayor Riesgo de IM

L.A. McKeown

October 04, 2013

News Daily News

Nonvalvular A-fib Patients More Likely to Remain on Dabigatran Than Warfarin

Jason Kahn

August 12, 2013

News Daily News

El Uso de Anticoagulantes Orales contra la FA en Prácticas de la Comunidad parece Apropiado

June 21, 2013

News Daily News

Danish Registry Suggests Aspirin Unnecessary in A-fib Patients After MI or PCI

Caitlin E. Cox

June 20, 2013

News Daily News

Un Registro Danés Sugiere que la Aspirina No es Necesaria en Pacientes con FA tras un IM o PCI

Caitlin E. Cox

June 20, 2013

News Daily News

Novel Anticoagulants Cost-Effective vs. Warfarin in A-fib Patients

Caitlin E. Cox

May 13, 2013

Advertisement

Una Gran Minoría de Pacientes con Fibrilación Auricular de Bajo Riesgo Siguen Recibiendo Anticoagulantes

Editor’s Corner: The Watchman Story

El Uso Crónico de un Antagonista de la Vitamina K Aumenta las Hemorragias Intrahospitalarias en Pacientes sometidos a PCI Primarias

Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation

Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation

Efficacy and Safety Profile of Pradaxa® (dabigatran etexilate) Repeatedly Confirmed

New study to investigate dabigatran etexilate for prevention of recurrent stroke in high-risk patients

ROCKET AF Substudy: Rivaroxaban Safe, Effective in East Asian Patients

ROCKET AF Analysis Isolates Predictors of Intracranial Hemorrhage in A-fib Population

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Meta-analyses: Novel Anticoagulants Halve Intracranial Hemorrhage vs. Warfarin

Meta Análisis: Comparados con la Warfarina los Nuevos Anticoagulantes Reducen a la Mitad las Hemorragias Intracraneales

Rivaroxaban Antidote Appears Safe, Effective in Early Study

Oral Direct Thrombin Inhibitors Linked to Increased MI Risk

Los Inhibidores Orales Directos de la Trombina se asocian a un Mayor Riesgo de IM

Nonvalvular A-fib Patients More Likely to Remain on Dabigatran Than Warfarin

El Uso de Anticoagulantes Orales contra la FA en Prácticas de la Comunidad parece Apropiado

Danish Registry Suggests Aspirin Unnecessary in A-fib Patients After MI or PCI

Un Registro Danés Sugiere que la Aspirina No es Necesaria en Pacientes con FA tras un IM o PCI

Novel Anticoagulants Cost-Effective vs. Warfarin in A-fib Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content